Ulrike Winkler Jenks

Array ( [id] => 7347500 [patent_doc_number] => 20040248081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'LANA viral protein binding sites' [patent_app_type] => new [patent_app_number] => 10/194046 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19179 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248081.pdf [firstpage_image] =>[orig_patent_app_number] => 10194046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6791929 [patent_doc_number] => 20030087273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => new [patent_app_number] => 10/186593 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15650 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087273.pdf [firstpage_image] =>[orig_patent_app_number] => 10186593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869836 [patent_doc_number] => 20030082525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Five-Helix protein' [patent_app_type] => new [patent_app_number] => 10/173570 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9220 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082525.pdf [firstpage_image] =>[orig_patent_app_number] => 10173570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289119 [patent_doc_number] => 20040110125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays' [patent_app_type] => new [patent_app_number] => 10/164290 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29080 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110125.pdf [firstpage_image] =>[orig_patent_app_number] => 10164290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750443 [patent_doc_number] => 20030044963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Compositions and methods for producing recombinant adeno-associated virus' [patent_app_type] => new [patent_app_number] => 10/146329 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12879 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044963.pdf [firstpage_image] =>[orig_patent_app_number] => 10146329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745173 [patent_doc_number] => 20030022356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for producing recombinant virus' [patent_app_type] => new [patent_app_number] => 10/141491 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13255 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022356.pdf [firstpage_image] =>[orig_patent_app_number] => 10141491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046839 [patent_doc_number] => 20020168346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Novel lentiviral packaging cells' [patent_app_type] => new [patent_app_number] => 10/112894 [patent_app_country] => US [patent_app_date] => 2002-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9599 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168346.pdf [firstpage_image] =>[orig_patent_app_number] => 10112894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024350 [patent_doc_number] => 06884576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-26 [patent_title] => 'Methods of monitoring HIV drug resistance' [patent_app_type] => utility [patent_app_number] => 10/112090 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13658 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884576.pdf [firstpage_image] =>[orig_patent_app_number] => 10112090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 944023 [patent_doc_number] => 06967076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-22 [patent_title] => 'Method for producing recombinant cells for detecting HIV' [patent_app_type] => utility [patent_app_number] => 10/112579 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 18755 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/967/06967076.pdf [firstpage_image] =>[orig_patent_app_number] => 10112579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817374 [patent_doc_number] => 20030068332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Replication-competent recombinant virus and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/104192 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20444 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068332.pdf [firstpage_image] =>[orig_patent_app_number] => 10104192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846710 [patent_doc_number] => 20030165877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Recombinant phages capable of entering host cells via specific interaction with an artificial receptor' [patent_app_type] => new [patent_app_number] => 10/104473 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11847 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165877.pdf [firstpage_image] =>[orig_patent_app_number] => 10104473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999357 [patent_doc_number] => 06911205 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-28 [patent_title] => 'Stabilized soluble glycoprotein trimers' [patent_app_type] => utility [patent_app_number] => 10/100534 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 22328 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911205.pdf [firstpage_image] =>[orig_patent_app_number] => 10100534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711816 [patent_doc_number] => 20030171565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Purified and isolated protein zero related (PZR) and therapeutic and screening method using same' [patent_app_type] => new [patent_app_number] => 10/095131 [patent_app_country] => US [patent_app_date] => 2002-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 35612 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171565.pdf [firstpage_image] =>[orig_patent_app_number] => 10095131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745888 [patent_doc_number] => 20030023071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'DNA encoding proteins that inhibit Hsp70 function' [patent_app_type] => new [patent_app_number] => 10/093246 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7906 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20030023071.pdf [firstpage_image] =>[orig_patent_app_number] => 10093246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6476436 [patent_doc_number] => 20020151708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'DNA encoding proteins that inhibit Hsp70 function' [patent_app_type] => new [patent_app_number] => 10/093045 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7984 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151708.pdf [firstpage_image] =>[orig_patent_app_number] => 10093045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982179 [patent_doc_number] => 06927023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Method of identifying modulators of HIV-1 Vpu and Gag interaction with U binding protein (Ubp)' [patent_app_type] => utility [patent_app_number] => 10/090378 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 11345 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927023.pdf [firstpage_image] =>[orig_patent_app_number] => 10090378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 452698 [patent_doc_number] => 07247439 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-07-24 [patent_title] => 'Method of evaluating a patient antibody response to envelope proteins of a virus' [patent_app_type] => utility [patent_app_number] => 10/077027 [patent_app_country] => US [patent_app_date] => 2002-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 24802 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/247/07247439.pdf [firstpage_image] =>[orig_patent_app_number] => 10077027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6562374 [patent_doc_number] => 20020164800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Retroviral vector' [patent_app_type] => new [patent_app_number] => 10/059265 [patent_app_country] => US [patent_app_date] => 2002-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6341 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164800.pdf [firstpage_image] =>[orig_patent_app_number] => 10059265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1027550 [patent_doc_number] => 06881410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-19 [patent_title] => 'Treatment of E. faecium infection' [patent_app_type] => utility [patent_app_number] => 10/054968 [patent_app_country] => US [patent_app_date] => 2002-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7618 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/881/06881410.pdf [firstpage_image] =>[orig_patent_app_number] => 10054968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6208390 [patent_doc_number] => 20020071849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Recombinant poxvirus' [patent_app_type] => new [patent_app_number] => 10/047761 [patent_app_country] => US [patent_app_date] => 2002-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10541 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20020071849.pdf [firstpage_image] =>[orig_patent_app_number] => 10047761 [rel_patent_id] =>[rel_patent_doc_number] =>)